Blue Jet Healthcare Ltd Share Price (BLUEJET)

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited at Mumbai dated December 7 1968. The name of Company was changed to Blue Jet Healthcare Private Limited and a fresh Certificate of Incorporation dated December 30 2020 was issued by the Registrar of Companies Mumbai. Subsequently Company got converted into a Public Limited and its name was changed to Blue Jet Healthcare Limited on May 18 2022. The Company is a specialty pharmaceutical and healthcare ingredient and intermediate company offering niche products toward innovator pharmaceutical companies and multinational generic pharmaceutical companies. It has operations organized into three product categories contrast media intermediates high intensity sweeteners and pharma intermediates and active pharmaceutical ingredients APIs. It is engaged in manufacturing of Pharma Intermediate APIs used in Pharmaceutical and Healthcare products.Since incorporation in 1968 the Company was established with the name Jet Chemicals Private Limited in Shahad Unit I by Late Shri B L Arora. It set up a contract development and manufacturing organization CDMO business model with specialized chemistry capabilities in contrast media intermediates and high intensity. In 1970 the Company began manufacturing saccharin and its salts which are highintensity sweeteners.In 2000 it entered the Xray contrast media sector with a basic building block 5 NIPA.In 2002 it started manufacturing of pharma intermediates and API.In 2003 it established Blue Circle Organics Private Limited at their UnitII Ambernath facility.In 2017 it started semiautomated manufacturing block for their contrast media intermediate business. The National Company Law Tribunal at Mumbai NCLT by way of its Order dated November 19 2020 sanctioned a Scheme of Merger amongst the Company Blue Circle Organics Private Limited and their respective shareholders and creditors and made it effective from December 28 2020. In 2020 it acquired a Unit III brownfield site in Mahad. In 2021 it acquired a Unit IV greenfield manufacturing site in Ambernath.The Company is planning to raise capital from Public by issuing 21683178 Equity Shares through Offer for Sale..

Revenue: ₹340.45Cr as on March 2025 (Q4 FY25)
Net Profit: ₹110.10Cr as on March 2025 (Q4 FY25)
Listing date: 01 Nov, 2023
Chairperson Name: Akshay Bansarilal Arora: